login
register
Home
Getting Started
ChartMill Overview
Growth Traders
Technical Swing Traders
Long Term Investors
Tools
Stock Screener
Stock Charts
Full Screen Stock Charts
Market Monitor
Sectors
Earnings
Analyzer
Insider Trading
Up- and Downgrades
Stock Market
Top Gainers and Losers
New 52 Week High and Low
Gap Up and Gap Down
Most Active
Premarket Movers
After-Hours Movers
Earnings Calendar
USA Market Overview
Canada Market Overview
Europe Market Overview
Trading Ideas
News
Blog
Documentation
Documentation Center
Videos
Indicators
Properties
Screener Market data
Popular Articles
Bull Flags
Relative Strength
Pocket Pivots
Support and Resistance
RSI Indicator
MACD Indicator
Piotroski F-score
Squeeze Plays
Weinstein
Technical Breakout Setups
Trading Tips
Premarket Movers
Gap Up Stocks
Best Dividend Stocks
Bullish Engulfing Pattern
Ascending Triangle Pattern
Swing Trading
All articles ...
Subscriptions
Swing Trading Course
Account
Disclaimer
Affiliate
Contact
Privacy
BIOLINERX LTD-SPONS ADR (BLRX) Stock News
USA
-
Nasdaq
- NASDAQ:BLRX -
US09071M2052
-
ADR
3.2
USD
-0.14 (-4.19%)
Last: 12/2/2025, 8:00:02 PM
Overview
Stock Chart
Technical Analysis
Fundamental Analysis
Analyst Ratings
Earnings Estimates
Financials
Ownership
News
BLRX Latest News, Press Relases and Analysis
All
Press Releases
9 days ago - By: BioLineRx Ltd.
BioLineRx Reports Third Quarter 2025 Financial Results and Provides Corporate Update
14 days ago - By: Benzinga
- Mentions:
BRTX
IBO
VNRX
XBIO
...
12 Health Care Stocks Moving In Wednesday's After-Market Session
15 days ago - By: BioLineRx Ltd.
BioLineRx to Report Third Quarter 2025 Results on November 24, 2025
2 months ago - By: BioLineRx Ltd.
BioLineRx Ltd. and Hemispherian AS Establish Joint Venture to Develop GLIX1, a First-in-Class, Oral, Small Molecule Targeting DNA Damage Response in Glioblastoma and Other Cancers
3 months ago - By: Benzinga
- Mentions:
PRQR
SXTC
CNSP
BCAB
...
12 Health Care Stocks Moving In Tuesday's After-Market Session
4 months ago - By: BioLineRx Ltd.
BioLineRx Reports Second Quarter 2025 Financial Results and Provides Corporate Update
4 months ago - By: BioLineRx Ltd.
BioLineRx to Report Second Quarter 2025 Results on August 14, 2025
5 months ago - By: Yahoo Finance
H.C. Wainwright Reaffirms Buy on BioLineRx Ltd. (BLRX) After ASCO 2025
6 months ago - By: Yahoo Finance
- Mentions:
RY
RY.CA
SEDG
PATH
...
UiPath price target raised to $15 from $12 at TD Cowen
6 months ago - By: Yahoo Finance
- Mentions:
SEDG
PD
WETO
BDRX
...
BioLineRx upgraded to Buy from Hold at JonesResearch
6 months ago - By: Yahoo Finance
- Mentions:
RY
RY.CA
SPWR
PD
...
PagerDuty price target lowered to $17 from $18 at TD Cowen
6 months ago - By: Yahoo Finance
- Mentions:
RY
RY.CA
ULTA
ZS
...
Zscaler price target raised to $290 from $245 at Evercore ISI
6 months ago - By: Yahoo Finance
- Mentions:
LMT
JPM
SEDG
LHX
...
L3Harris Technologies price target raised to $270 from $240 at TD Cowen
6 months ago - By: Stocktwits
- Mentions:
GILD
BioLineRx Stock Jumps On Positive Data from Pilot Phase Of Pancreatic Cancer Drug Trial: Retail Cheers The ‘Buy’ Rating
6 months ago - By: Stocktwits
BioLineRx Q1 Earnings Rise Despite Fall In Revenue: Retail Stays Super Confident
6 months ago - By: BioLineRx Ltd.
BioLineRx Reports First Quarter 2025 Financial Results and Provides Corporate Update
7 months ago - By: BioLineRx Ltd.
BioLineRx to Report First Quarter 2025 Results on May 27, 2025
8 months ago - By: BioLineRx Ltd.
BioLineRx Reports 2024 Financial Results and Provides Corporate Update
8 months ago - By: BioLineRx Ltd.
BioLineRx to Report 2024 Annual Results on March 31, 2025
Please enable JavaScript to continue using this application.